CKD and Albuminuria Management — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Add ACE inhibitor (or ARB) and titrate to maximum tolerated dose
Explanation lettering: E = shown as A · C = shown as B · A = shown as C · B = shown as D · D = shown as E
KDIGO recommends ACE inhibitor or ARB in patients with CKD and albuminuria (A2/A3) to reduce progression; titrate to maximally tolerated dose while monitoring creatinine and potassium. Thiazide (A) aids BP but does not replace RAAS blockade; beta blocker (D) and MRA (E) are not first add-ons for albuminuric CKD; (C) is incorrect.
Reference: KDIGO Guideline (2024): Evaluation and Management of Chronic Kidney Disease